Wogonin glucuronidation in liver and intestinal microsomes of humans, monkeys, dogs, rats, and mice
Wogonin glucuronidation in liver and intestinal microsomes of humans, monkeys, dogs, rats, and mice
复制标题
DOI:
10.1080/00498254.2020.1725180
复制
发表时间:
2020-02-11
期刊:
影响因子:
1.8
通讯作者:
Ohkawara, Susumu
中科院分区:
文献类型:
--
作者:
Hanioka, Nobumitsu;Isobe, Takashi;Ohkawara, Susumu
Wogonin, one of the flavonoids isolated from Scutellaria baicalensis, exhibits some beneficial bioactivities, including anti-inflammatory and anticancer effects, and is metabolized into glucuronide by UDP-glucuronosyltransferase (UGT) enzymes in humans. In the present study, wogonin glucuronidation was examined in the liver and intestinal microsomes of humans, monkeys, dogs, rats, and mice using a kinetic analysis. The kinetics of wogonin glucuronidation by liver microsomes followed the biphasic model in all species examined. CLint values (x-intercept) based on v versus V/[S] plots were rats > humans approximate to monkeys > mice > dogs. The kinetics of intestinal microsomes fit the Michaelis-Menten model for humans, monkeys, rats, and mice and the substrate inhibition model for dogs. CLint values were rats > monkeys > mice > dogs > humans. The tissue dependence of CLint values was liver microsomes > intestinal microsomes for humans, dogs, and rats, and liver microsomes approximate to intestinal microsomes for monkeys and mice. These results demonstrated that the metabolic abilities of UGT enzymes toward wogonin in the liver and intestines markedly differ among humans, monkeys, dogs, rats, and mice, and suggest that species differences are closely associated with the biological effects of wogonin.